Home / Health / Pakistan Ends Medicine Shortages: 35 Drugs Priced
Pakistan Ends Medicine Shortages: 35 Drugs Priced
27 Apr
Summary
- Government approved prices for 35 essential medicines.
- Critical drug shortages have impacted patient treatment.
- Pharmaceutical association hailed the government's decision.
The federal government has officially approved the pricing for 35 new essential and life-saving medicines, with an additional 45 molecules anticipated for clearance shortly. This significant decision addresses critical shortages that have severely impacted patient access to necessary treatments across Pakistan.
Health Minister Syed Mustafa Kamal presented the urgency of the situation to Prime Minister Shehbaz Sharif and the cabinet, emphasizing that prolonged delays in price fixation had disrupted supply chains and endangered lives. The affected medicines include critical therapies such as oncology drugs, transplant medicines, cardiovascular treatments, and essential vaccines.
The Pakistan Pharmaceutical Manufacturers' Association (PPMA) lauded the government's move, describing it as a timely intervention that would help restore the availability of critical therapies and improve patient outcomes. For over two years, the PPMA had been highlighting how delays in price approvals restricted access to essential medicines, forcing reliance on potentially unsafe, unregulated alternatives.
This price fixation aims to resolve long-standing issues that limited therapeutic choices and created serious treatment gaps, particularly for patients with chronic conditions. The government's renewed focus on price control for essential drugs signals a turning point for the healthcare system.
